Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Buyouts - USD or CAD
View:
Post by plantrader on Jan 17, 2023 4:46pm

Buyouts - USD or CAD

When suggesting a buyout figures such as $3 billion, are most of you referencing USD or CAD?
Comment by N0taP00p on Jan 17, 2023 4:57pm
Theralase uses USD for their $1.1B to $1.7B revenue opportunity projections. So I'm guessing we're all using USD. 
Comment by plantrader on Jan 17, 2023 4:58pm
$3B USD would be juicyyyyyyyy
Comment by ScienceFirst on Jan 17, 2023 5:39pm
Plantrader ...  The best way for you to understand biotechs market valuations on takeovers or on jv is to look to different news.   Ballpark estimates, based on what we often see for disruptive technologies: - If TLT was only a one-indication biotech that was to become the SOC for NMIBC, it would be acquired for approx. 3B$US, given the size of the NMIBC market and assuming 284M ...more  
Comment by ScienceFirst on Jan 17, 2023 5:41pm
Lets take then CAinPlap's 302M fully diluted share count then, instead of my 284M one.  
Comment by plantrader on Jan 17, 2023 6:00pm
ScienceFirst, Thanks for the info. Very helpful summary and context.
Comment by ScienceFirst on Jan 17, 2023 5:02pm
Always in US$.  As per the news in US mdias show it. Biotechs that get acquired are usually listed on NASDAQ, so in US currency. ______________   plantrader - (1/17/2023 4:46:17 PM) Buyouts - USD or CAD When suggesting a buyout figures such as $3 billion, are most of you referencing USD or CAD? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250